tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CRMD Stock Latest News

Cormedix’s Strategic Growth: Melinta Acquisition and Rezzayo’s Market Expansion Justify Buy Rating
RatingsCormedix’s Strategic Growth: Melinta Acquisition and Rezzayo’s Market Expansion Justify Buy Rating
2d ago
CRMD
Cormedix’s Positive Outlook: Buy Rating Backed by Strong Sales Guidance and Strategic Initiatives
PremiumRatings
Cormedix’s Positive Outlook: Buy Rating Backed by Strong Sales Guidance and Strategic Initiatives
10d ago
CRMD
CorMedix makes $5M minority equity investment in Talphera
PremiumThe Fly
CorMedix makes $5M minority equity investment in Talphera
18d ago
CRMD
TLPH
CorMedix Completes Acquisition of Melinta Therapeutics
PremiumCompany Announcements
CorMedix Completes Acquisition of Melinta Therapeutics
24d ago
8K
CRMD
CorMedix appoints new leadership team following Melinta acquisition
PremiumThe Fly
CorMedix appoints new leadership team following Melinta acquisition
25d ago
CRMD
CorMedix completes acquisition of Melinta Therapeutics
PremiumThe FlyCorMedix completes acquisition of Melinta Therapeutics
25d ago
CRMD
CorMedix sees FY25 pro forma revenue $325M-$350M
Premium
The Fly
CorMedix sees FY25 pro forma revenue $325M-$350M
25d ago
CRMD
CorMedix Inc. Advances in Infection Prevention with DEFENCATH® Study
Premium
Company Announcements
CorMedix Inc. Advances in Infection Prevention with DEFENCATH® Study
1M ago
CRMD
Cormedix Inc. Advances Pediatric Study on DefenCath® for Infection Prevention
PremiumCompany Announcements
Cormedix Inc. Advances Pediatric Study on DefenCath® for Infection Prevention
1M ago
CRMD
CorMedix Completes $150M Convertible Notes Offering
PremiumCompany Announcements
CorMedix Completes $150M Convertible Notes Offering
2M ago
8K
CRMD
CorMedix Inc. Earnings Call Highlights Strategic Growth
PremiumCompany Announcements
CorMedix Inc. Earnings Call Highlights Strategic Growth
2M ago
CRMD
CorMedix price target lowered to $17 from $20 at H.C. Wainwright
PremiumThe Fly
CorMedix price target lowered to $17 from $20 at H.C. Wainwright
2M ago
CRMD
CorMedix Inc. Reports Strong Q2 2025 Results
PremiumCompany AnnouncementsCorMedix Inc. Reports Strong Q2 2025 Results
2M ago
CRMD
M&A News: CorMedix Stock (CRMD) Plunges 11% Despite $300M Melinta Deal
Premium
Market News
M&A News: CorMedix Stock (CRMD) Plunges 11% Despite $300M Melinta Deal
2M ago
CRMD
Cormedix’s Strategic Growth Potential Boosted by Melinta Therapeutics Acquisition
Premium
Ratings
Cormedix’s Strategic Growth Potential Boosted by Melinta Therapeutics Acquisition
2M ago
CRMD
CorMedix Announces Merger Agreement with Melinta Therapeutics
PremiumCompany Announcements
CorMedix Announces Merger Agreement with Melinta Therapeutics
2M ago
8K
CRMD
CorMedix sees FY25 pro forma revenue $305M-$335M
PremiumThe Fly
CorMedix sees FY25 pro forma revenue $305M-$335M
2M ago
CRMD
CorMedix to acquire Melinta Therapeutics for $300M
PremiumThe Fly
CorMedix to acquire Melinta Therapeutics for $300M
2M ago
CRMD
CorMedix reports Q2 EPS 28c, consensus 19c
PremiumThe Fly
CorMedix reports Q2 EPS 28c, consensus 19c
2M ago
CRMD
CRMD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsCRMD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
CRMD
CorMedix Inc. Advances Pediatric Dialysis Safety with New Clinical Study
Premium
Company Announcements
CorMedix Inc. Advances Pediatric Dialysis Safety with New Clinical Study
3M ago
CRMD
CorMedix’s DEFENCATH® Study: A Potential Game-Changer in Infection Prevention
Premium
Company Announcements
CorMedix’s DEFENCATH® Study: A Potential Game-Changer in Infection Prevention
3M ago
CRMD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >